Nexgard Spectra 75 mg (Afoxolaner TABLET (CHEWABLE)) 75 MG

NEXGARD SPECTRA 75 MG is a chewable tablet designed for oral use in pets. It combines afoxolaner for comprehensive flea and tick prevention, ensuring your pet's well-being. Ideal for pet owners seeking reliable parasite control.

Strength

75 MG

Manufacturer / TM Owner

BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

NEXGARD SPECTRA 75 MG is primarily used for the prevention and treatment of flea and tick infestations in pets. It targets various stages of flea and tick life cycles, providing long-lasting protection. Pet owners often ask, 'What is NEXGARD SPECTRA used for?'—it's a trusted solution for maintaining pet health by controlling common parasites.

Side Effects

NEXGARD SPECTRA 75 MG works by disrupting the nervous system of fleas and ticks, leading to their death. Pet owners may notice a reduction in flea and tick activity within 24 hours of administration. The chewable form makes it easy to administer, ensuring pets receive the necessary protection without stress.

Precautions & Warnings

Always consult a veterinarian before administering NEXGARD SPECTRA 75 MG, especially if your pet has a history of seizures or is on other medications. Store the tablets in a cool, dry place away from children and pets. Monitor your pet for any adverse reactions after administration.

Avoid Interactions

NEXGARD SPECTRA 75 MG may interact with other medications, particularly those that affect the nervous system. It's important to inform your veterinarian about all medications your pet is currently taking. Avoid administering with other flea and tick treatments unless directed by a professional.

Frequently Asked Questions

NEXGARD SPECTRA 75 MG is used for the prevention and treatment of flea and tick infestations in pets.

NEXGARD SPECTRA 75 MG works by disrupting the nervous system of fleas and ticks, leading to their death.

Consult a veterinarian before administering NEXGARD SPECTRA 75 MG, especially if your pet has a history of seizures or is on other medications.

Pet owners may notice a reduction in flea and tick activity within 24 hours of administration.

Inform your veterinarian about all medications your pet is currently taking to avoid potential interactions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.